Watch now

Conference

The Hi Korea conference programme offers you high-level sessions featuring opinion leaders from government and academia.

As a leading learning platform for trends and issues confronting the health ingredients & pharmaceutical industry in Korea and the region, the Hi Korea conference is an integral part of the event, and will give you a realistic assessment of the industry challenges, and strategies for dealing with them.

Hi Korea 2016 Conference Programme

Tuesday, August 23
 
◈ Session 1
14:00 - 14:50 GMP Compliance Inspection by PMDA PMDA
GMP Inspector
Shiki
Kumiko
14:50 - 15:05 Q&A
15:05 - 15:20 Break Time
15:20 - 16:10 The Latest Information on Japan Pharmacopeia and Master Files PMDA
Technical Officer
Suzuki
Shogo
16:10 - 16:25 Q&A

* Japanese → Korean

 
Wednesday, August 24
 
◈ Session 2
10:10 - 11:00 The success strategy to enter EU market with some cases of most frequent mistakes for (Korean) pharmaceutical companies with respect to the API's used(an oversight of the regulatory process in the EU and an overview of the API information ) APIC
Global Regulatory Specialist
Marieke
van Dalen
11:00 - 11:15 Break Time
11:15 - 12:05 Case Study - most common deficiencies in the EU, also with focus on the API's
12:05 - 12:20 Q&A

* English → Korean

◈ Session 3
14:00 - 14:50 Value of Generic Medicines / Registration of Medicines in Europe Medicines for Europe(Former EGA) Market Access Director Maarten
Van Baelen
14:50 - 15:05 Break Time
15:05 - 15:55 Pricing Policies of Generic Medicines in Europe
15:55 - 16:10 Q&A

* Englsih → Korean

 
Thursday, August 25
 
◈ Session 4
10:10 - 11:00 Korea Regulatory Harmonization of Bioequivalence Study National Institute of Food and Drug Safety Evaluation(NIFDS) Reviewer & Scienctific Officer Jimyoung Kim
11:00 - 11:15 Break Time
11:15 - 12:05 Current Status and Prospect of KP(Korean Pharmacopeia) National Institute of Food and Drug Safety Evaluation(NIFDS) Deputy Director Seongjun Yang
12:05 - 12:20 Q&A

* Korean → English

◈ Session 5
13:00 - 14:00 New Normal: Challenges and Opportunities of China Pharma Market IMS Health President Brian Mi
14:00 - 14:10 Q&A
14:10 - 15:10 Licensing and M&A Deal Trend
- Boosting External Innovation with Creative Partnership
Thomson Reuters Professional Consultant Young Joo Oh
15:10 - 15:20 Q&A

* Korean → English / English → Korean

Conference Registration Speakers Free Seminar